Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study

https://ift.tt/SV7srXF

 

from Sanofi - Aventis Groupe https://ift.tt/Sbfp6LR
via IFTTT